| Autor: |
Gish RG; Hepatitis B Foundation, Doylestown, Pennsylvania, USA., Wong RJ; Division of Gastroenterology and Hepatology, Veterans Affairs Palo Alto Healthcare System, Stanford University School of Medicine, Palo Alto, California, USA., Di Tanna GL; Department of Business Economics, Health and Social Care, University of Applied Sciences and Arts of Southern Switzerland, Manno, Switzerland., Kaushik A; Gilead Sciences Inc., Global Value and Access, Foster City, California, USA., Kim C; Gilead Sciences Inc., Global Value and Access, Foster City, California, USA., Smith NJ; Maple Health Group, LLC, HEOR, New York, New York, USA., Kennedy PTF; Barts Liver Centre, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK. |
